Hila Magen

13PUBLICATIONS
48CO-AUTHORS
AnaesthesiologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 22, 2026
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.

|Nov 13, 2025
High Implementation Adherence to Lenalidomide in Multiple Myeloma.

Irina Amitai, Hila Magen, Avi Leader

|Apr 11, 2025
The Impact of Melphalan Conditioning and CD34 + Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis.

Eli Muchtar, Vaishali Sanchorawala, Hamza Hassan

|Feb 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis.

Eli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala

|May 01, 2023
Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders.

Hila Magen, Abraham Avigdor, Lee Nevo

|Mar 29, 2023
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World Study.

Eyal Lebel, Efstathios Kastritis, Giovanni Palladini

Pageof 3

Frequent Collaborators

3 joint publications

Muzaffar Qazilbash

3 joint publications

Ute Hegenbart

3 joint publications

Angela Dispenzieri

3 joint publications

Rajshekhar Chakraborty